Related Experiment Video
Updated: Feb 11, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
[Current Understanding of Myeloproliferative Neoplasm-Related Gene Mutations and Cytokine -Review]
1Department of Hematology, Union Hospital, Fujian Medical University; Fujian Key Laboratory of Hematology, Fujian Institute of Hematology,Fuzhou 350001,Fujian Province,China.
Abstract:
Myeloproliferative neoplasm(MPN) is clonal hematopoietic stem cell disorder characterized by abnormal proliferation and expansion of one or more myeloid lineages. BCR-ABL-negative MPN includes polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). The mutations of JAK2, CALR and MPL genes are involved in the pathogenesis of MPN that provided a more complete molecular diagnostic standard for MPN. More and more new mutated genes related to prognosis of MPN were discovered in the past few years, at same time it was found that cytokines were also involved in the genesis and development of MPN. These provide a theoretical basis for the diagnosis, risk stratification and treatment management of MPN. In this article, the mechanisms of MPN-related cytokines and mutated genes in the genesis and development of disease and prognosis characteristics are summarized.
Insights
Myeloproliferative neoplasms (MPN) are stem cell disorders. This review summarizes how mutated genes and cytokines impact MPN development, prognosis, and treatment.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell disorders.
- BCR-ABL-negative MPNs include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
Purpose of the Study:
- To summarize the mechanisms of MPN-related cytokines and mutated genes.
- To review their roles in disease genesis, development, and prognosis.
Main Methods:
- Literature review of recent discoveries in MPN pathogenesis.
- Analysis of the roles of JAK2, CALR, and MPL gene mutations.
- Examination of cytokine involvement in MPN.
Main Results:
- Mutations in JAK2, CALR, and MPL genes are key in MPN pathogenesis.
- Novel mutated genes influencing MPN prognosis are continually being discovered.
- Cytokines play a significant role in the initiation and progression of MPN.
Conclusions:
- Understanding mutated genes and cytokines provides a basis for MPN diagnosis and risk stratification.
- These insights support the development of targeted treatment strategies for MPN.
- Further research into these mechanisms will refine MPN management.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Viral Mutations

